News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Yellow Labrador Retriever, Sage, Deployed on USS Gerald R. Ford as Part of the FIRST Expanded Operational Stress Control Canine Pilot Program

Mutts with a Mission

NORFOLK, VA, May 05, 2023 - McapMediaWire - Sage, a three-year-old female yellow Labrador Retriever, has been deployed aboard the aircraft carrier USS Gerald R. Ford, as part of the Expanded Operational Stress Control Canine pilot program. This innovative program is aimed at providing a unique outlet and comfort for Sailors during deployment, with the goal of helping them cope with the operational stress associated with their work. Sage is part of the warfighter toughness mental health and resiliency team on the Gerald R. Ford and is specially trained to help Sailors deal with the challenges of deployment. Animals have been proven to be an effective form of stress relief and can provide a sense of companionship, which is why Sage is expected to be an invaluable asset to the crew during their deployment. Allen Fabijan or “Some Guy Named Allen” a Puppy Raiser and trainer with Mutts with a Mission, a Virginia-based non-profit organization accredited by Assistance Dogs International, helped to raise and train Sage. “We knew Sage was special, we just had no idea what a special role Sage would have the honor of playing for so many deserving sailors. There is no doubt she is the best choice for the Crew of the Gerald R. Ford and the EOSC program,” said Fabijan. The Gerald R. Ford will be the first U.S. Navy ship to have an expanded operational stress control (EOSC) canine as part of the crew throughout deployment. Chaplain Genevieve Clark, Gerald R. Ford and Carrier Strike Group 12’s Chaplain, will serve as Sage’s primary handler while on deployment. In preparation for deploying with Sage, Clark completed 120 hours of handler training with Mutts with a Mission. Three other volunteer handlers aboard the Ford also support Clark in Sage's care and mission. “One of the positives of having Sage aboard the ship is her help in breaking down some barriers to utilizing mental, emotional, and spiritual resiliency resources,” said Clark. “Sailors are coming to more warrior toughness events and improving their morale through the vast network of resiliency resources the ship offers with Sage now present at these opportunities.” During deployment, all Sailors will benefit from spending time with Sage, who will be present with Chaplains, Resiliency Providers, and Mental Health professionals. Sage will be available to Sailors during ship-wide Morale, Welfare, and Recreation events, and her daily schedule will be made available to Sailors for general visitation and morale boosts throughout the day. Mutts with a Mission sent Sage with all necessary supplies for deployment, including a waste collection mat, proper bedding located in the handler’s stateroom, personal protective gear including paw, hearing, and eye protection, and a life vest. “The Sailors of Gerald R. Ford are excited to welcome Sage to the ship. Mutts with a Mission provides an invaluable service to Sailors, one that will aid in stress relief during the ship’s deployment,” said Capt. Rick Burgess, Ford’s commanding officer. “Sage is one of the many resources aboard the ship to help Sailors build resiliency and enhance morale.” The deployment of the USS Gerald R. Ford Carrier Strike Group (GRFCSG) is currently ongoing in the Atlantic Ocean in support of interoperability and maritime security. In total, the GRFCSG is deployed with more than 6,000 Sailors across all platforms ready to respond globally to combatant commander tasking. For more information on Mutts with a Mission, please visit https://www.muttswithamission.org/. For More information on Allen Fabijian “Some Guy Names Allen”, visit https://www.instagram.com/someguynamedallen or https://us1061.com/some-guy-named-allen/ Contact Details Mutts with a Mission info@muttswithamission.org Company Website https://www.muttswithamission.org/

May 05, 2023 09:53 AM Eastern Daylight Time

Image
Article thumbnail News Release

GBB Drink Lab Files $53M Lawsuit Against FSD Pharma for Nondisclosure Contract Breach and Trade Secret Misappropriation

GBB Drink Lab

GBB Drink Lab (“GBB” or the “Company”), maker of the world’s first formulated drink that aids in rapid blood alcohol detoxification, has announced that the Company has filed a lawsuit against FSD Pharma (NASDAQ: HUGE) (“FSD”), a publicly traded biotechnology company that operates in the pharmaceutical research and development business. As a result of FSD Pharma’s failure to comply with a Cease-and-Desist letter sent by GBB on April 14 th, 2023, the Company has subsequently filed a $53 million complaint for material breach of a mutual nondisclosure agreement and trade secret misappropriation. Filed on May 1 st, 2023, in the U.S. District Court for the Southern District of Florida, the complaint alleges that after seven months of exploring a business opportunity of mutual interest and benefit revolving around GBB’s blood alcohol detoxification drink, FSD Pharma publicly announced the misappropriation of GBB’s trade secrets to current and prospective investors in one of its press releases. In the press release, FSD Pharma discussed the launch of a new research and development program targeting unmet medical needs for alcohol misuse and deliberately omitted the underlying misappropriation. GBB’s lawsuit alleges that FSD Pharma used GBB’s proprietary and confidential material to raise capital, persuade iconic entrepreneurs to join its advisory board, and drive up the price of FSD Pharma’s publicly traded stock. The Company is seeking compensatory and punitive damages as well as an injunction against FSD Pharma preventing further unlawful disclosure and use of the Company’s trade secrets. The lawsuit has been filed in the U.S. District Court for the Southern District of Florida under the name GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC. with case number: 0:23-cv-60800-AHS. GBB has a patented formula that accelerates the process of converting alcohol to sugar in the body. By enhancing the metabolic pathways that facilitate this process, the formula can help the body clear alcohol much faster than normal. The Company has been working on a proprietary drink for several years using its patented formula. About GBB Drink Lab GBB Drink Lab started with a vision of making a positive impact by offering practical, evidence-based solution to reducing Blood Alcohol Content. The company’s product has been meticulously crafted to optimize your ability to sober up thus enabling you to escape an inebriated state. GBB Drink Lab leadership team includes accomplished serial entrepreneurs, a former senior executive from one of the world’s largest beverage companies, and an industry-leading expert in flavoring science and product formulation. For more information, visit https://gbbdrinklab.com/. Media Contact Jarrett Boon Co-Founder, CEO, GBB Drink Lab, Inc Jarrett@gbbdrinklab.com 602-456-1555 Contact Details GBB Drink Lab Jarrett@gbbdrinklab.com Company Website https://gbbdrinklab.com/

May 05, 2023 08:45 AM Eastern Daylight Time

Article thumbnail News Release

CleverTap appoints Benjamin Roodman as Vice President, Partnerships, North America

CleverTap

CleverTap, the all-in-one engagement platform, named Benjamin Roodman as Vice President, Partnerships for North America. In his new role, Benjamin will lead CleverTap’s channel and technical partner strategy – developing and managing relationships to drive CleverTap’s growth within the region. With over two decades of experience across the board, Benjamin has spent the past 13 years strengthening relations with business and channel partners. His appointment will help CleverTap build a more fruitful partner ecosystem within North America and further cement their position as market leaders in the region. Benjamin joins CleverTap from AppsFlyer where he was the AVP of Business Development. In his previous roles he has led partnerships across mobile SaaS, digital advertising, and cloud platforms. He is well versed in mobile growth platforms with a notable aptitude for analytics. “We are thrilled to have Benjamin on board. With the wealth of knowledge and experience he brings to the team, he will help drive growth in North America – a key-market for us.” said Momchil Kyurkchiev, Chief Strategy Officer at CleverTap. “Our channel and technical partners are an integral part of our growth strategy. To establish a robust partner ecosystem, it is crucial to collaborate with them and incorporate tools that offer innovative solutions to unanticipated issues. I am confident that with Benjamin’s appointment we will continue to build a world-class partner ecosystem and drive value for our customers.” “I am ecstatic to embark on this new journey and make a measured impact with CleverTap. A strong foundation in North America, and a burgeoning partner ecosystem, are a testament of CleverTap’s commitment within the region. At CleverTap, we understand the importance of building a robust partner network to further penetrate markets and provide exceptional service to our customers.” said Benjamin. “I look forward to working closely with our partners to develop innovative solutions that meet the evolving needs of our customers and accelerate their success. Together we will continue to drive innovation, foster collaboration, and build a stronger base for our expansion.” About CleverTap CleverTap is the all-in-one customer engagement platform that helps brands personalize and optimize all consumer touch points to improve user engagement, retention, and lifetime value. It's the only solution built to address the needs of retention and growth teams, with audience analytics, deep-segmentation, multi-channel engagement, product recommendations, and automation in one unified product. The platform is powered by TesseractDB™ – the world’s first purpose-built database for customer engagement, offering both speed and economies of scale. CleverTap is trusted by 2000 customers, including Electronic Arts, TiltingPoint, Gamebasics, Big Fish, MobilityWare, TED, English Premier League, TD Bank, Carousell, AirAsia, Papa John’s, and Tesco. Backed by leading investors such as Sequoia India, Tiger Global, Accel, and CDPQ the company is headquartered in Mountain View, California, with presence in San Francisco, New York, São Paulo, Bogota, London, Amsterdam, Sofia, Dubai, Mumbai, Singapore, and Jakarta. For more information, visit clevertap.com or follow on LinkedIn and Twitter. Forward-Looking Statements Some of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release. Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction. Contact Details Sony Shetty sony@clevertap.com Company Website https://clevertap.com/

May 04, 2023 07:00 AM Pacific Daylight Time

Article thumbnail News Release

Can Someone Explain the Snail Secretion Skincare Craze?

Caracol Natural Skincare

Caracol Natural Skincare, NEW to the US, is a natural skincare brand that uses snail secretion as the key ingredient. Steeped in tradition, this Chilean based family-owned skincare brand has combined Chilean ancient medicine with modern technology and is now available in the US on AMAZON. Founded in 2006, Caracol Natural is a beautiful story of people in harmony with nature, with high admiration for Chilean and global ancestral medicine, and with the conviction that skincare with natural eco-friendly ingredients, along with premium actives, can offer better-faster-stronger results. The use of snail secretion (also known as snail mucin) in cosmetics can be traced back to ancient Greece, where Hippocrates reportedly prescribed snails for skin inflammation. In the 20th century, snail farmers in Chile noticed that their hands became softer and smoother after handling snails, which led to the development of snail-based creams for hand care. The use of snail secretion in skincare products again gained popularity in the 1990s, when a group of Chilean farmers developed a snail cream that became a best-seller in Korea. Since then, snail secretion has been incorporated into a wide range of skincare products, including creams, serums, masks, and lotions. One of the most interesting aspects of snail secretion is its ability to improve skin health in multiple ways. Snail secretion is a complex mixture of compounds, including hyaluronic acid, glycolic acid, allantoin, antioxidants, and peptides, that can work together to provide a range of benefits for the skin. Another interesting aspect of snail secretion is that it is a natural ingredient that is sustainably sourced. Snail farming is a relatively low-impact agricultural practice that doesn't require large amounts of water or land, making it an environmentally friendly option. Here are some of the main benefits of snail secretion: Hydration: Snail secretion contains hyaluronic acid, glycolic acid, and allantoin, which help to hydrate and moisturize the skin. This can help to reduce the appearance of fine lines and wrinkles, and leave the skin looking plump and supple. Anti-aging: Snail secretion contains antioxidants, peptides, and other compounds that can help to reduce the signs of aging. It may help to improve skin elasticity, reduce the appearance of dark spots, and improve skin texture. Healing: Allantoin, a compound found in snail secretion, has been shown to have wound-healing properties. It may help to reduce inflammation, speed up the healing process, and reduce the risk of scarring. Soothing: Snail secretion has a soothing effect on the skin, which can help to reduce redness and irritation. This makes it particularly beneficial for people with sensitive skin. Brightening: Snail secretion contains glycolic acid, which can help to brighten the skin and reduce the appearance of dark spots and hyperpigmentation. The Caracol Natural lineup includes: The Gentle Cleanser - $22.99 The Gentle Cleanser Facial Foam Expert gently removes impurities while respecting your natural skin barrier. This gentle face wash formula includes Snail Secretion Filtrate plus 8 Clearing Vegetal Extracts like Nettle, Aloe Vera, Sage and Rosemary that helps restore skin balance. Our formula is fitter for sensitive, delicate, dry, flaky, worn, dull, sallow skin, nevertheless is recommended for balancing oily skin and suitable for all skin types The Eye Contour Serum - $32.99 The Eye Contour Serum hydrates, moisturizes, refreshes and restores the healthy appearance of the delicate skin around the eye. It helps to depuff, reduce dark circles and sagginess, lessen oxidative stress, minimize and prevent fine lines and crow's feet. Our Eye Contour Serum helps to brighten, firm, plump, lift, soothe and smooth skin to sustain and recover a radiant, lively and healthier look. The Gentle Serum - $35.99 The Premium Gentle Serum is designed to restore and maintain firmer, denser, flexible, healthier, radiant and bouncier skin. Our Skin Care Gentle Serum for Face and Neck helps subside fine lines, wrinkles, sagginess and dullness. It lessens oxidative stress, it hydrates, moisturizes, softens, calms, plumps, and boosts skin wellbeing, bestowing a beautiful and youthful complexion. Texture Reform Cream - $32.99 The Texture Reform Cream feels soft, silky, light, cool and fresh; it moisturizes and hydrates efficiently without leaving a greasy feeling; it appeals to anyone grease-averse. It helps to brighten up dull and lackluster skin, care for the balance of normal to oily skin, sensitized and acne prone skin (it is not medicinal), lessen oxidative stress, minimize and prevent the appearance of fine lines and wrinkles, keep in check aging and strengthen the skin barrier. Caracol Natural Skincare is NOW available on AMAZON. Contact Details CARACOL NATURAL SKINCARE Dianne Vavra / Spotlight Beauty +1 917-331-4869 Company Website https://caracol-skincare.com/en/

May 04, 2023 09:03 AM Eastern Daylight Time

Image
Article thumbnail News Release

Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it has executed a Term Sheet for a firm committed underwriting with a nationally recognized investment banking firm for $10,000,000 with respect to planned corporate financing transactions, including the private placement of securities (“pre-IPO Financings”) and the planned $10 million initial public offering of Emergent subsidiary PharmaZu common stock (“IPO”) that will be applied for listing on NASDAQ or NYSE/AMEX, with NO DILUTION to Emergent shareholders. PharmaZu is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including pet pharmacy, vet telehealth and pet wellness businesses. Upon the effectiveness of the IPO and listing on a national exchange, PharmaZu plans to acquire a 48-state authorized compounding pharmacy located in West Palm Beach, FL, doing approximately $10M a year in revenue, which will serve as the backbone and fulfilment center for PharmaZu, creating a national platform throughout the United States. Subsequently, Emergent plans to distribute to its shareholders, pro rata, the shares of PharmaZu as a dividend, when a record date is set. The raise of capital will be used for expanding PharmaZu’s business, product offerings, as well as for acquisitions. Jim Morrison, former L'Oréal President and Emergents full time CEO stated, “The transaction with Boustead will start a new exciting chapter for PharmaZu, while maximizing the value to Emergent’s shareholders.” Adam Books, President of PharmaZu stated, “PharmaZu is poised to start its disrupting of the mail order pet business and pet medications, as well as advancing the tele-pet med environment. I am very thrilled to be a part of this.” The execution of the Engagement Letter does not constitute a commitment by Boustead or the Company to consummate any transaction contemplated hereunder and does not ensure the successful placement of securities of any investment vehicle or the success of Boustead with respect to finding any investors or the success with respect to any transaction. No promises, representations or guarantees have been made. ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website info@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 04, 2023 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Two Hands Corporation Announces Asset Sale of gocart.city

Two Hands Corporation

Two Hands Corporation, (CSE: TWOH) (OTC: TWOH) a Delaware company in the grocery and e-commerce sector, is pleased to announce the sale of its gocart.city business, including its e-commerce site, branding, Grocery Originals store, and inventory to a private buyer effective May 1, 2023. Under the terms of the Memorandum of Understanding (MOU), the buyer has acquired the assets of gocart.city. The sale includes the e-commerce site, branding, supporting components of the Grocery Originals store, and inventory. The ongoing sales and client base will also be transferred as part of the transaction. Two Hands CEO, Nadav Elituv, commented, "We believe this transaction is in the best interest of our shareholders and will allow us to focus on our core operations while reducing our debt by $134,700. We are confident in the buyer's ability to continue the growth and success of gocart.city." As part of our strategic plan to refocus on core operations, Two Hands will be dedicating resources towards its growing food service business. The company has seen growth and opportunities in this sector, with an increase in both the number of customers and sales. Two Hands has also strengthened relationships with strategic suppliers, resulting in better overall margins for the company. "We are excited about the growth and opportunities in our food service business and are committed to investing in its continued success," added Elituv ABOUT TWO HANDS CORPORATION Two Hands Corporation, (OTC: TWOH) is a food distribution company operating under the Cuore Food Services brand. Please visit our website at www.twohandsgroup.com This press release contains forward-looking statements that involve a number of risks and uncertainties. Any statement not regarding a historical fact is a forward-looking statement. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to, the company's ability to finance its planned expansion efforts; the company's ability to raise funds on acceptable terms; the company's ability to successfully adapt its business model and such other risks disclosed from time to time in the company's reports filed with the securities and exchange commission including those on the company's annual report on form 10-K. The company does not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in management's expectations, except as required by law. CONTACT: Two Hands Corporation IR@twohandsapp.com www.twohandsgroup.com www.gocart.city Contact Details Two Hands Corporation IR@twohandsapp.com

May 04, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Bragg Gaming reveals plans for expansion into new gaming markets in Europe and Mexico

Bragg Gaming Group

Bragg Gaming chief strategy officer Yaniv Spielberg joins Proactive's Natalie Stoberman to share the company's plans for expansion into Europe and Central America. Bragg Gaming Group is a fast-growing, vertically integrated, global business-to-business online gaming and content technology supplier. Its products and services collectively represent a full turnkey solution with everything required to set up and operate online and omni-channel casino, sportsbook and lottery brands. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

May 03, 2023 11:32 AM Eastern Daylight Time

Video
Article thumbnail News Release

Austin-based chief medical officer commits to health equity in Central Texas by joining local American Heart Association Board of Directors

Centre for Neuro Skills

Centre for Neuro Skills (CNS), a leader in brain injury rehabilitation services, and The American Heart Association (AHA), the world’s leading nonprofit organization focused on heart and brain health for all, today announced Dr. Matthew Ashley as a new member of the AHA’s Board of Directors in Central Texas. Dr. Ashley is the chief medical officer for CNS. “I am honored to join the Central Texas American Heart Association board and serve our community by improving heart health and stroke awareness with the AHA,” said Dr. Ashley. “For nearly 100 years, the American Heart Association has been ensuring longer, healthier lives through innovative educational efforts including stroke prevention and treatment. I look forward to our partnership for large-scale community efforts focused on public education and awareness regarding brain injuries.” Earlier this year, the AHA and CNS announced that they are working together to deepen connections with healthcare providers, patients and caregivers while raising awareness of post-stroke care throughout Texas and California. “The Central Texas Board of Directors continues to guide the American Heart Association as we address health disparities throughout our area,” said Sara Harwood, Region Senior Vice President of the American Heart Association. “The addition of Centre for Neuro Skills and Matt Ashley to our Board brings more insight and ideas as we deepen our understanding and ready for action on all aspects of health and well-being.” During Dr. Ashley’s nine-year tenure at CNS, he has served as a consulting neurologist, treating a diverse spectrum of patients recovering from traumatic and acquired brain injury. Dr. Ashley is a noted speaker, who lectures at universities and seminars focusing on stroke, epilepsy, dementia, neuroradiology and brain injury rehabilitation. Dr. Ashley received both his medical and juris doctor degrees from Southern Illinois University. He completed a neurology residency at UCLA, as well as a neurological rehabilitation fellowship at the university’s renowned Neurological Rehabilitation and Research Unit. CNS opened its newest clinic in Austin in June, 2021. The 17,000 square ft. facility can serve 60 patients and is located at 14425 Falconhead Blvd. ### About Centre for Neuro Skills Centre for Neuro Skills is an experienced and respected world leader in providing intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced care from residential and assisted living to outpatient/day treatment. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas. For more information, visit neuroskills.com, Facebook, Twitter, LinkedIn, YouTube. For a video overview of CNS, visit our YouTube channel. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Visit heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1. Contact Details Landis Communications Inc. Robin Carr +1 415-766-0927 cns@landispr.com American Heart Association Megan Jameson +1 512-338-2639 megan.jameson@heart.org Company Website https://www.neuroskills.com/

May 03, 2023 08:32 AM Pacific Daylight Time

Image
Article thumbnail News Release

Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space, is pleased to announce that it has regained its “Pink Current Information” status with the OTC Markets, a major milestone in the company's continued growth and development and is now current with all required mandatory disclosure filings again. Jim Morrison, former L'Oréal President and Emergent’s full-time CEO stated “We’ve been working diligently with OTC Markets since being classified as “Pink Sheet Limited Information” several weeks ago and took all the necessary steps to regain “Pink Current Information” status. Achieving this status is a testament to Emergent’s commitment to excellence and full transparency with the intent to create long-term trust and value for our shareholders. Moving forward, we have taken steps to ensure this never occurs again with regard to OTC Market mandatory disclosure requirements. This achievement would not have been possible without the hard work and dedication of our entire team, and we are grateful for their efforts”. Yesterday on May 2, 2023, Emergent announced revenues of $373,406 for the quarter ended December 31, 2022 as compared to $185,471 for the quarter ended September 30, 2022, an increase of over 100% and revenues of $574,613 for the Year Ended December 31, 2022 as compared to $119,567 for the year ended December 31, 2021, an increase of over 380%. The financial statement can be viewed in its entirety at OTC Markets. The global b iologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030. A biologic medication is a product that is made from live organisms and contains living organism components. Examples of biologics are Recombinant protein, tissues, allergens, genes, cells, blood components, blood, and vaccinations are all examples of biologics. Examples of what can be treated are Anemia, hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis, inflammatory bowel disease, and other disorders and infections are treated with biologics. Our focus is on aesthetics cosmetics and men’s and women’s health, but also wound care and tissue regeneration. Various government efforts, higher share of biologics in the market, and rising use of biopharmaceuticals over chemically produced molecules, and many other factors are driving the biologics market expansion in the forecast period. ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website i nfo@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 03, 2023 10:53 AM Eastern Daylight Time

1 ... 7475767778 ... 259